This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Events & Webinars
  • Podcasts
  • Resources
  • Learning Zone
  • Products
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer cross colorful
Bayer for ProfessionalsYour Resource Portal
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Ophthalmology Events & Webinars
    Early Insights Case Study Webinar Series
    Key experts in medical retina, from both the UK and the US, discuss their patient cases
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2577, November 2024
    Effective Collaboration through Teamwork:
    How Bristol Eye Unit and BNSSG ICB developed a sustainable patient pathway for Medical Retina
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2410, August 2024
    Value-Based Prescribing:
    Enhancing NHS efficiency and sustainability in Ophthalmology Care
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2409, August 2024